Child cancer scenarios. GP CME Rotorua 2014
|
|
- Madeleine Lynch
- 5 years ago
- Views:
Transcription
1 Child cancer scenarios GP CME Rotorua 2014
2 Scenario 1 Chickenpox is in the school What is the response when the parent of a child on chemotherapy rings the practice?
3 Scenario 2 -chickenpox Varicella is a significant risk in the immunocompromised patient and can result in severe illness and death (though usually doesn t!) Many calls will not actually involve personal contact of the immunocompromised child with the infectious child and are false alarms There is no requirement to keep the child out of school because there is chickenpox around (it always is!)
4 Scenario 1-chickenpox Zoster immune globulin (ZIG) or pooled immunoglobulin (Intragam) can be given early or a course of 7 days aciclovir (80mg/kg/day in 4 divided doses) beginning 7 days after exposure (the period of potential viremia) These will be given at the hospital. Regard as potentially infectious for 28 days VZIG or IVIg protection only lasts 4 weeks, then start all over again!
5 Scenario 2 The family presents with a child on chemotherapy. The presenting condition is one that is familiar to the GP, commonly occurs in general practice and you are confident to manage the condition. What additional aspects should be considered?
6 Scenario 2- intercurrent illness Is the child unwell/ febrile? Is the child reasonably well but likely to be neutropenic? Does the child have a central venous line? How far away from the hospital are you? Almost always, you will call the local paediatrician for advice.
7 Scenario 2 Occasionally, where a child s home is remote with the likelihood of a significant delay before definitive care can be provided at the hospital, we have provided a febrile neutropenia pack with instruction for the local GP. This includes blood culture bottles, a broad spectrum parenteral antibiotic and where appropriate a special needle to access the portacath.
8 Scenario 3 You are asked to provide care at home to a child who is dying from cancer for which all reasonable curative therapies have been exhausted. You haven t had contact with the child since diagnosis because all treatment has taken place at the local hospital and Starship although you have received regular communication from the hospitals and from the family about what has been happening.
9 Scenario 3 palliative care More than half of the 20% of child cancer patients who are not cured will die at home. While specialist palliative care services are available in many places and the oncology team remains involved, the GP is often asked to take an important role in providing care. This is not expected to be undertaken without suitable support, advice and information.
10 Scenario 4 The Mum of a 7 year old who recently completed treatment for ALL presents to your practice requiring reimmunisation. What is involved?
11 Scenario 4 Immunity returns to normal at 6 months (12 months after stem cell transplant) Often there is no or patchy protection despite earlier vaccination Serology checked and individualized catch up programme provided New immunisation schedule which should make it more straightforward to reimmunise and claim.
12 Scenario 5 A 14 year old boy with AML experienced life threatening toxicity during treatment but is now off treatment and 4 years disease free. He is at risk of late morbidity from his treatment having been exposed to relatively high cumulative doses of anthracycline Do you as his GP have a role in his ongoing care?
13 Scenario 5-late effects follow-up He is now at negligible risk for relapse. His major risk is now from the consequences of his treatment. He will have a Health Passport detailing all his treatment and his surveillance testing to date (including ECG and echocardiogram results) He will also have a list of recommended follow-up investigations and timings for those.
14 Scenario 5 late effects follow-up Is this kind of care appropriate for primary care? Are tests done in secondary care accessible to you?
15 Scenario 6 A young woman of 17 has been discharged from oncology follow-up after treatment for ALL when she was 7. She is cured of leukaemia She had no demonstrable late effects of therapy at discharge from the hospital clinic What is your strategy for her health care?
16 Scenario 6 routine health care In spite of increasingly better tailored treatment for ALL and reduction in anthracycline and alkylating agents, late effects continue to be seen. Early aging and in particular, early onset of metabolic syndrome is being reported in survivorship series. Monitoring for this should be incorporated in well patient care
17 Scenario 7 The parents of an 8 year old child with lymphoma decline the treatment which offers her a 75% chance of cure because of their religious beliefs. What is your role in such a circumstance?
IMMUNISATION OF CHILDREN DURING and AFTER CANCER THERAPY
NATIONAL GUIDELINES PAEDIATRIC ONCOLOGY AND HAEMATOLOGY For the Care of Childhood Cancer in Specialist Child Cancer and Shared Care Centres. IMMUNISATION OF CHILDREN DURING and AFTER CANCER THERAPY Date
More informationVaccination to protect against shingles
Vaccination to protect against shingles - An update for registered healthcare practitioners The programme from September 2018 and contraindications and precautions Revised July 2018 NES and HPS accept
More informationGuidelines for immunisation of children following treatment with high dose chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT)
Guidelines for immunisation of children following treatment with high dose chemotherapy and Haematopoietic Stem Cell Transplantation (HSCT) Version 2.0 Approved by Haem / Onc Senior Clinical Management
More informationWessex Paediatric Oncology Supportive Care Guidelines: off treatment follow up ALL
Wessex Paediatric Oncology Supportive Care Guidelines: off treatment follow up ALL Scope This guideline applies to all paediatric oncology patients in the region. It does not apply to neonates on neonatal
More informationViral Infections. 1. Prophylaxis management of patient exposed to Chickenpox:
This document covers: 1. Chickenpox post exposure prophylaxis 2. Chickenpox treatment in immunosuppressed/on treatment patients 3. Management of immunosuppressed exposed to Measles All children with suspected
More informationQuestions & Answers 1 November 2005 Vaccine Schedule
Questions & Answers 1 November 2005 Vaccine Schedule General Questions Q. When can clinics order the new vaccine? A. From early October 2005. Orders will be placed on back order & stock will be sent out
More informationImmunisations in Adult End stage kidney disease update 2016
Additional Notes During work up (predialysis or dialysis) Awaiting (live donor or on deceased donor list) Post Renal Transplant on immunosuppression Vaccinate Annually: Influenza (eg Influvac, Flurix)
More informationA summary of guidance related to viral rash in pregnancy
A summary of guidance related to viral rash in pregnancy Wednesday 12 th July 2017 Dr Rukhsana Hussain Introduction Viral exanthema can cause rash in pregnant women and should be considered even in countries
More informationDepartment of Health. Year 8. vaccination program. Important information for parents and students
Department of Health Year 8 vaccination program Important information for parents and students Contents Why immunise? 1 Vaccination program 1 Schedule of vaccinations 2 Vaccination records 2 Vaccine safety
More informationShingles Procedure. (IPC Policy Manual)
Shingles Procedure (IPC Policy Manual) DOCUMENT CONTROL: Version: 1.1 Ratified by: Clinical Policy Approval Group Date ratified: 3 July 2018 Name of originator/author: Senior Clinical Nurse Specialist
More informationLRI Children s Hospital. Management of chicken pox exposure in paediatrics
LRI Children s Hospital Management of chicken pox exposure in paediatrics Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team approval date: October 018 Version: V 3 Revision
More informationVaccination to protect against shingles - An update for registered healthcare practitioners
Vaccination to protect against shingles - An update for registered healthcare practitioners The programme from September 2016 and contraindications and precautions September 2016 NES and HPS accept no
More informationChapter 16 Pneumococcal Infection. Pneumococcal Infection. August 2015
Chapter 16 16 PPV introduced for at risk 1996 PCV7 introduced for at risk 2002 and as routine 2008 PCV13 replaced PCV7 in 2010 NOTIFIABLE In some circumstances, advice in these guidelines may differ from
More informationBackground Rationale for resource Note: Shingles is also known as herpes zoster. For the purpose of this resource the
Slide 1 Background The Joint Committee on Vaccination and Immunisation 1 reviewed all the available medical, epidemiological and economic evidence as well as vaccine safety and efficacy relevant to offering
More informationPatient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st May 2014 Expiry Date: 30 th April 2017
Patient Group Direction for Varicella vaccine Version: Varicella 2014.1 Start Date: 1 st May 2014 Expiry Date: 30 th April 2017 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationPatient Group Direction for Varicella vaccine Version: Varicella Start Date: 1 st April 2016 Expiry Date: 31 st March 2019
Patient Group Direction for Varicella vaccine Version: Varicella 2016.1 Start Date: 1 st April 2016 Expiry Date: 31 st March 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:
More informationBackground Rationale for resource
Background The Joint Committee on Vaccination and Immunisation 1 reviewed all the available medical, epidemiological and economic evidence as well as vaccine safety and efficacy relevant to offering a
More informationFAQ s for parents. Why is my child being offered the flu vaccine?
FAQ s for parents Who is being offered the flu vaccine? This year all healthy children aged 2 years to 13 years old in Leicester, Leicestershire and Rutland will be offered a vaccination against flu. Children
More informationAdministration of shingles (herpes zoster) vaccine (live) Zostavax. Version 7.0 updated for programme from September 2017 to August 2018
Patient Group Direction template Administration of shingles (herpes zoster) vaccine (live) Zostavax Version 7.0 updated for programme from September 2017 to August 2018 This specimen Patient Group Direction
More informationSTANDARD OPERATING PROCEDURE (SOP) CHICKENPOX [VARICELLA ZOSTER VIRUS (VZV)]
Page 1 of 9 SOP Objective To ensure that patients with chickenpox (Varicella Zoster Virus) are cared for appropriately and actions are taken to minimise the risk of cross-infection. This SOP applies to
More informationAged 70 or 78? There s now a vaccine to help protect you against shingles
Aged 70 or 78? There s now a vaccine to help protect you against shingles This leaflet describes shingles and the benefits of the vaccination. The new shingles vaccine is being phased in over the next
More informationGuidelines for the immunisation of children following treatment with Standard-Dose Chemotherapy
Guidelines for the immunisation of children following treatment with Standard-Dose Chemotherapy Version 2.0 Approved by Haem / Onc Senior Clinical Management team Date Approved March 2015 Ratified by:
More informationChickenpox Procedure. (IPC Policy Manual)
Chickenpox Procedure (IPC Policy Manual) DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Policy Approval Group Date ratified: 3 July 2018 Name of originator/author: Senior Clinical Nurse Specialist
More informationCARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS
CARE PATHWAY FOR CHILDREN AND YOUNG PERSONS WITH FEBRILE NEUTROPENIA, NEUTROPENIC SEPSIS OR SUSPECTED CENTRAL VENOUS LINE INFECTIONS This Care Pathway has been developed by a multidisciplinary team. It
More informationIMMUNIZATION PROTOCOLS FOR PHARMACISTS. VARICELLA Live Virus Vaccine
IMMUNIZATION PROTOCOLS FOR PHARMACISTS VARICELLA Live Virus Vaccine I. ORDER: 1. Screen for contraindications and evidence of immunity (Section VII.K.) 2. Provide a current Vaccine Information Statement
More informationOutpatient care for patients with neutropenia. Information for patients Weston Park Hospital
Outpatient care for patients with neutropenia Information for patients Weston Park Hospital page 2 of 8 Information for patients who have neutropenia and are going home with oral antibiotics. What is neutropenia?
More informationBackground Rationale for resource
Slide 1 Background The Joint Committee on Vaccination and Immunisation 1 reviewed all the available medical, epidemiological and economic evidence as well as vaccine safety and efficacy relevant to offering
More informationIf these vaccines haven t been given, please follow guidelines below for emergency procedures.
MANAGEMENT OF PATIIENTS POST SPLENECTOMY & HYPOSPLENIIC PATIIENTS Splenectomised and hyposplenic patients are at increased risk of life-threatening infections due to encapsulated micro-organisms such as
More informationDeaths in New Zealand and the Need for Palliative Care
Clinical Stream Deaths in New Zealand and the Need for Palliative Care Professor Heather McLeod Deaths in New Zealand and the Need for Palliative Care National Rural Health Conference Rotorua, March 2015
More informationManchester Royal Infirmary. Antibody Deficiency. Information For Patients
Manchester Royal Infirmary Antibody Deficiency Information For Patients 1 What is Immunodeficiency? Immunodeficiency is the name given to the condition of having a faulty immune system which reduces your
More informationVaccination against shingles for adults aged 70 and 79 years of age Q&A s for healthcare professionals
Vaccination against shingles for adults aged 70 and 79 years of age Q&A s for healthcare professionals Background In 2010, the Joint Committee on Vaccination and Immunisation (JCVI) 1 were asked by the
More informationINTERPRETING HEPATITIS B SEROLOGY
INTERPRETING HEPATITIS B SEROLOGY RECOMMENDED WORDING FOR NATIONAL LABORATORIES TO REPORT HEPATITIS B DIAGNOSTIC TEST RESULTS THIS DOCUMENT HAS BEEN ENDORSED BY: Australasian Society for HIV Medicine,
More informationVARICELLA. Dr Louise Cooley Royal Hobart Hospital
VARICELLA Dr Louise Cooley Royal Hobart Hospital Varicella Zoster Virus (VZV): The Basics Herpes virus Exclusively human infection Primary infection: varicella (chickenpox) Neurotropic, establishing latency
More informationImmunization for Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients
Immunization for Adult Recipients January 4, 201 Immunization for Adult Hematopoietic Stem Cell Transplant () Recipients Revision Date: January 4, 201 Note: This guide is meant to supplement existing recommendations
More informationSupportive Care makes excellent cancer care possible
Supportive Care makes excellent cancer care possible Irma Verdonck-de Leeuw With many thanks to Age Schultz and Dorothy M Keefe Supportive Care in Cancer The prevention & management of the adverse effects
More informationSpots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox
Chickenpox Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox Noelle Bessette, MPH Surveillance Specialist New Jersey Department of Health Vaccine Preventable Disease Program Caused
More informationDon t let your child catch it
Don t let your child catch it The number of children catching measles is rising across the United Kingdom and Europe, including Northern Ireland. To prevent this, children need to be immunised with MMR
More informationSpots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox
Spots and Pox: Contact Tracing and Follow Up for Measles and Chickenpox Noelle Bessette, MPH Surveillance Specialist New Jersey Department of Health Vaccine Preventable Disease Program Chickenpox Caused
More informationChickenpox Notification
Goolwa Campus: (08) 8555 7500 Victor Harbor Campus: (08) 8551 0900 Investigator College Chickenpox Notification Date for Distribution: 2018 Dear Parents/Caregivers There has been a case of chickenpox reported
More informationImmunization for Child Hematopoietic Stem Cell Transplant (HSCT) Recipients
Immunization for Child Recipients January 4, 201 Immunization for Child Hematopoietic Stem Cell Transplant () Recipients Revision Date: January 4, 201 Note: This guide is meant to supplement existing recommendations
More informationDon t let your child catch it
Don t let your child catch it The number of children catching measles is rising. To prevent this, children need to be immunised with MMR vaccine. Children under the age of 18 years who have missed their
More informationSAMPLE. PGD Reviewed by: Chris Faldon, John Maloney, Tim Patterson, Adrian MacKenzie, Claire Stein
Patient Group Direction for the supply or administration of haemophilus influenzae type B and meningococcal conjugate vaccine to children requiring immunisation as part of the national childhood vaccination
More informationAre you protected against measles mumps and rubella?
Are you protected against measles mumps and rubella? You re not if you haven t had MMR vaccine This leaflet tells you about measles, mumps and rubella and the MMR vaccination which helps protect against
More informationInformation for trans people
NHS Screening Programmes Public Health England leads the NHS Screening Programmes About this leaflet This leaflet is for trans (transgender) and non-binary people in England. It tells you about the adult
More informationSouthern Derbyshire Shared Care Pathology Guidelines. Varicella Zoster Virus (VZV)
Southern Derbyshire Shared Care Pathology Guidelines Varicella Zoster Virus (VZV) Purpose of guideline This guideline provides information about the definition of significant exposure to VZV and management
More informationpatient group direction
ACICLOVIR v01 1/8 ACICLOVIR PGD Details Version 1.0 Legal category Staff grades Approved by POM Paramedic (Non-ECP) Nurse (Non-ECP) Emergency Care Practitioner (Paramedic) Emergency Care Practitioner (Nurse)
More informationICM VI-09 DEFINITION REFERENCES
TITLE/DESCRIPTION: MANAGEMENT OF SELECTED AIRBORNE AND DROPLET INFECTIOUS DISEASE EXPOSURES IN HEALTHCARE WORKERS INDEX NUMBER: EFFECTIVE DATE: APPLIES TO: ISSUING AUTHORITY: 01/01/2009 01/01/2013 All
More informationUnderstanding Parkinson s for health and social care staff. The phases of Parkinson s
Understanding for health and social care staff The phases of The phases of Diagnosis 11% 1.6 Post diagnosis before symptoms have become significant Maintenance 40.4% 5.9 Symptoms significant but largely
More informationAdministration of Hepatitis A and B Vaccine
PRACTICE: Ref No: PGD/ONEL/2011/006 Valid from December 2011 Valid to December 2013 Supersedes PGD: Any previous PGD used to administer Twinrix Adult and Paediatric vaccine Professional groups covered
More informationAged 70 or 78? There s a vaccine to help protect you from the pain of shingles
Aged 70 or 78? There s a vaccine to help protect you from the pain of shingles This leaflet describes shingles and the benefits of the vaccination and who is eligible for the vaccine this year. There is
More informationIgG subclass deficiencies
IgG subclass deficiencies hello@piduk.org 0800 987 8986 www.piduk.org About this booklet This booklet provides information on IgG subclass deficiencies. It has been produced by the PID UK Medical Advisory
More informationSingle Technology Appraisal (STA) Arsenic trioxide for treating acute promyelocytic leukaemia
Single Technology Appraisal (STA) Arsenic trioxide for treating acute promyelocytic leukaemia Response to consultee and commentator comments on the draft remit and draft scope (pre-referral) Please note:
More informationTerm 3 Calendar of Events Save the Date!
Newsletter Edition 26, Week 26 Friday 17th August, 2018 Term 3 Calendar of Events Save the Date! WK MONDAY TUESDAY WEDNESDAY THURSDAY FRIDAY 20 August 21 August 22 August 23 August 24 August 6 Book Week
More informationBLINCYTO can eliminate detectable traces of cancer 1
For people* with B-cell precursor ALL who are MRD+, 1 BLINCYTO can eliminate detectable traces of cancer 1 In a study of 86 adults with MRD+ B-cell precursor ALL, BLINCYTO removed detectable traces of
More informationPILOT STUDY PROPOSAL FOR EARLY DISCHARGE OF LOW-RISK NEUTROPENIC PATIENTS
PILOT STUDY PROPOSAL FOR EARLY DISCHARGE OF LOW-RISK NEUTROPENIC PATIENTS RATIONALE: It is increasingly being recognised that not all neutropenic patients have the same risk of complications during episodes
More informationWessex Paediatric Oncology Guidelines: Management of viral infections, viral prophylaxis and vaccination guidance
Wessex Paediatric Oncology Guidelines: Management of viral infections, viral prophylaxis and vaccination guidance Scope This guideline applies to all Paediatric Oncology patients in the region. It does
More informationReducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway
Reducing the Door to Needle Time for Antibiotics in Suspected Neutropenic Sepsis using a Dedicated Clinical Pathway Dr Alex Williams, Oncology Specialty Doctor. Cheltenham General Hospital Oncology Centre
More informationCiclosporin 25mg, 50mg, 100mg capsules Ciclosporin oral solution 100mg/ml
Shared Care Protocol Ciclosporin for the treatment of rheumatoid arthritis Name of drug, form and strength Background Ciclosporin 25mg, 50mg, 100mg capsules Ciclosporin oral solution 100mg/ml Ciclosporin
More informationSERVICE SPECIFICATION 6 Conservative Management & End of Life Care
SERVICE SPECIFICATION 6 Conservative Management & End of Life Care Table of Contents Page 1 Key Messages 2 2 Introduction & Background 2 3 Relevant Guidelines & Standards 2 4 Scope of Service 3 5 Interdependencies
More informationLaboratory Investigation of. Infectious Diarrhoea. Quiz Feedback. bpac nz better medicine
Laboratory Investigation of Infectious Diarrhoea Quiz Feedback bpac nz better medicine GP Review Panel: Dr Janine Bailey, Motueka Dr Stephen Kuzmich, Wellington Dr Randall Sturm, Auckland Dr Neil Whittaker,
More informationPalliative Care Asking the questions that matter to me
Palliative Care Asking the questions that matter to me THE PALLIATIVE HUB Adult This booklet has been developed by the Palliative Care Senior Nurses Network and adapted with permission from Palliative
More informationSHOULD VACCINES BE COMPULSORY?
The Big Debate SHOULD VACCINES BE COMPULSORY? Friday 02 March 2018 SHOULD VACCINES BE COMPULSORY? THE DILEMMA A change in French law means that all parents must now vaccinate children born on 1 January
More informationMyeloma Haematology and Transplant Unit MPT
MPT Myeloma Haematology and Transplant Unit MPT This leaflet is offered as a guide to you and your family. The possible benefits of treatment vary; for some people chemotherapy may reduce the risk of the
More informationSupportive Care For Hematological Malignancies
Supportive Care For Hematological Malignancies Nawaf Alkhayat, MD Pediatric Hematology, Oncology & BMT Prince Sultan Military Medical City Riyadh, KSA Supportive care Definition Why we need supportive
More informationCurricular Components for Hematology/Oncology EPA
Curricular Components for Hematology/Oncology EPA 1. EPA Title Manage patients with hematology-oncology conditions, whether acute or chronic, simple or complex, in an ambulatory, emergency, or inpatient
More informationDr Ewan Hutchison UK Civil Aviation Authority. ICAO European Regional Civil Aviation Medicine Seminar/Workshop București November 2013
Dr Ewan Hutchison UK Civil Aviation Authority ICAO European Regional Civil Aviation Medicine Seminar/Workshop București 11-15 November 2013 Types of Cancer Recertification after treatment Certification
More informationDecision to amend access criteria for some vaccines
3 July 2015 Decision to amend access criteria for some vaccines PHARMAC is pleased to announce the following changes to the funding access criteria for a number of vaccines. The changes in criteria follow
More informationAtlantic Provinces Pediatric Hematology Oncology Network Réseau d oncologie et d hématologie pédiatrique des provinces de l Atlantique
Atlantic Provinces Pediatric Hematology Oncology Network Réseau d oncologie et d hématologie pédiatrique des provinces de l Atlantique Reviewed and approved by specialists at the IWK Health Centre, Halifax,
More informationThe Changing Face of Childhood Vaccination. Dr Terry Coll National Immunisation Meeting 16 th April 2007
The Changing Face of Childhood Vaccination Dr Terry Coll National Immunisation Meeting 16 th April 2007 IRELAND MANY CHANGES IN LAST 7-10 YEARS LARGE MOVEMENT OF PEOPLE WITHIN THE COUNTRY FOR JOBS AND
More informationTo provide guidance on prevention and control of illness caused by varicella-zoster virus (VZV).
Effective Date: 04/18 Replaces: 0 4 / 1 3 / 1 7 Page 1 of 4 POLICY: To provide guidance on prevention and control of illness caused by varicella-zoster virus (VZV). DEFINITIONS Two syndromes occur from
More informationWelcome to Lliswerry Medical centre. Helpful patient information
Welcome to Lliswerry Medical centre Helpful patient information Ebola The risk of Ebola to the general public in the UK remains very low. Ebola can only be transmitted by direct contact with the blood
More informationGuideline for the Management of Fever and Neutropenia in Children with Cancer and/or Undergoing Hematopoietic Stem-Cell Transplantation
Guideline for the Management of Fever Neutropenia in Children with Cancer /or Undergoing Hematopoietic Stem-Cell Transplantation COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive
More informationkeyword: hepatitis Hepatitis
www.bpac.org.nz keyword: hepatitis Hepatitis Key reviewers: Dr Susan Taylor, Microbiologist, Diagnostic Medlab, Auckland Dr Tim Blackmore, Infectious Diseases Physician and Microbiologist, Wellington Hospital,
More informationAfter Soft Tissue Sarcoma Treatment
After Soft Tissue Sarcoma Treatment Living as a Cancer Survivor For many people, cancer treatment often raises questions about next steps as a survivor. What Happens After Treatment for Soft Tissue Sarcomas?
More informationStandard care plan for Carboplatin and Etoposide Chemotherapy References
CHEMOTHERAPY CARE PLAN Document Title: Document Type: Subject: Approved by: Currency: Carboplatin/Etoposide Chemotherapy Clinical Guideline Standard Care Plan 2 Years Review date: Author(s): Standard care
More informationNorthumbria Healthcare NHS Foundation Trust. Bronchiectasis. Issued by Respiratory Medicine
Northumbria Healthcare NHS Foundation Trust Bronchiectasis Issued by Respiratory Medicine The aim of this booklet is to help you manage your bronchiectasis. It contains information which you should find
More informationTRANSPARENCY COMMITTEE OPINION. 8 November 2006
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 8 November 2006 MABTHERA 100 mg, concentrate for solution for infusion (CIP 560 600-3) Pack of 2 MABTHERA 500 mg,
More informationNeutropenic Sepsis Acute General Management and Support. Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology
Neutropenic Sepsis Acute General Management and Support Ernie Marshall Macmillan Consultant in Medical Oncology Clatterbridge Centre for Oncology Who Am I? I am A Medical Oncologist (MCCN) Site specialist
More informationAzathioprine Shared Care Guideline for GPs
Indication: Azathioprine Shared Care Guideline for GPs Active rheumatoid arthritis and other types of inflammatory arthritis, systemic lupus erythematosus, dermatomyositis and polymyositis, vasculitis
More informationPediatric Oncology: Vaccination After Therapy Family Practice Oncology CME Day November 2017
Pediatric Oncology: Vaccination After Therapy Family Practice Oncology CME Day November 2017 S. Rod Rassekh Pediatric Oncologist BC Children s Hospital Objectives Discuss the immune system and vaccination
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationMANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSP There are no translations available. MANAGEMENT OF FEVER IN PEDIATRIC PATIENTS FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION
More informationNCCP Chemotherapy Regimen. LEAM Autologous Transplant Conditioning Protocol
INDICATIONS FOR USE: LEAM Autologous Transplant Conditioning Protocol Regimen *Reimbursement INDICATION ICD10 Code Status Autologous conditioning in non-hodgkins Lymphoma (NHL) C85 00468a Hospital Autologous
More informationVaccine administration. Dr Brenda Corcoran National Immunisation Office
Vaccine administration Dr Brenda Corcoran National Immunisation Office School immunisation programme Workshop 21 st April 2015 Overview Contraindications/ Precautions Adverse events 4 in 1 vaccine HPV
More informationWest of Scotland Difficult Asthma Group Statement of Practice
West of Scotland Difficult Asthma Group Statement of Practice Member Health Boards: Ayrshire and Arran Dumfries and Galloway Forth Valley Lanarkshire Glasgow ADVICE NOTE FOR INTRAMUSCULAR TRIAMCINOLONE
More informationTelethon Speech and Hearing (TSH) Health Policy
Telethon Speech and Hearing (TSH) Health Policy TSH aims to provide a safe and healthy environment for all staff, parents and children. Young children are particularly at risk of infection, and of spreading
More informationChickenpox Death. West Virginia Electronic Disease Surveillance System
Chickenpox Death Electronic Disease Surveillance System Division of Surveillance and Disease Control Infectious Disease Epidemiology Program Phone: 304-558-5358 or 800-423-1271 in Fax: 304-558-8736 Investigation
More informationRegeneron and Sanofi are financial supporters of The Skin Cancer Foundation and collaborated in the development of this article. US-ONC /2018
A D E E P E R L O O K When detected early, most cases of local cutaneous squamous cell carcinoma are easily treated and usually cured. But when they become more advanced, this second most common form of
More informationInfection in the Immunocompromised Patient
Infection in the Immunocompromised Patient POSG PI Infection 28 August 2008 1 INTRODUCTION... 4 Risk Factors 4 CLINICAL... 4 DISEASE-RELATED... 4 Important points 4 Prevention Of Infection 5 FEVER IN THE
More informationDAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES
DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES DISCLAIMER: This Clinical Practice Guideline (CPG) generally describes a recommended course of treatment for patients with the identified health
More informationoffers the possibility of a longer life 1 BLINCYTO A guide for patients and caregivers
In a study of 405 adults with Philadelphia chromosome negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia, 271 were treated with BLINCYTO and 134 with chemotherapy. The adults
More informationNo Jab, No Pay New Immunisation Requirements for Family Assistance Payments
No Jab, No Pay New Immunisation Requirements for Family Assistance Payments SUMMARY From 1 January 2016: Only parents of children (less than 20 years of age) who are fully immunised or are on a recognised
More informationPatient information. Subcutaneous Immunoglobulin Therapy and Home Treatment ( SCIG) Infection and Immunity Directorate PIF 1443 V2
Patient information Subcutaneous Immunoglobulin Therapy and Home Treatment ( SCIG) Infection and Immunity Directorate PIF 1443 V2 An overview of subcutaneous infusion of Immunoglobulin Many patients with
More informationIntegration of palliative care into oncology
1 Integration of palliative care into oncology Stein Kaasa European Palliative Care Research Centre, Faculty of Medicine, NTNU and Department of Oncology, St. Olavs Hospital, Trondheim University Hospital
More informationA Care Pathway exists for the management of neutropenic fever. Copies of the care pathway document are available in EAU, A&E, Deanesly and CHU.
Subject: Neutropenic Fever Guideline for Junior Doctors Date of Implementation: January 2010 Date of Review: January 2012 Director Responsible for Implementation and Review: Policy location: Consultant
More informationNursing and Midwifery students only. Section 1: Information
Nursing and Midwifery students only. Section 1: Information Students enrolled in programs offered by our School are REQUIRED to provide evidence of their immunisation status for the diseases listed in
More informationSummary of Activities in the Risk Management Plan (RMP) for DARZALEX (daratumumab)
DARZALEX - Risk Management Plan Summary of Activities in the Risk Management Plan (RMP) for DARZALEX (daratumumab) Document Version: 3.2 Document Date: 14 August 2018 Page 1 / 8 The Risk Management Plan
More informationI M VACCINATING FOR TWO NOW. IT S A LIFESAVER. Pregnant women and their babies are at risk from flu. Protect you and your baby - get your flu vaccine.
I M VACCINATING FOR TWO NOW. Pregnant women and their babies are at risk from flu. Protect you and your baby - get your flu vaccine. IT S A LIFESAVER www.im munisation.ie For more information, talk to
More informationAdult immunisation update training. August 2017
Adult immunisation update training August 2017 What we will cover Whooping cough vaccine in pregnant women Shingles vaccine update MMR for adults Hepatitis A and B shortages Pertussis vaccine in pregnancy
More informationA Case Review: Treatment-Naïve Patient with Head and Neck Cancer
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More information